Home
About
FAQ
History (11)
Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders.
Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes.
Helping Older Adults Improve Their Medication Experience (HOME) by Addressing Medication Regimen Complexity in Home Healthcare.
Moore, Laura
Clinical and consumer trial performance of a sensitive immunodiagnostic home test that qualitatively detects low concentrations of sperm following vasectomy.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (164)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Michael T. Munley PhD
Wake Forest School of Medicine
Why?
J. M. Cline DVM, PhD
Wake Forest School of Medicine
Why?
Michael D. Chan MD
Wake Forest School of Medicine
Why?
Thomas C. Register PhD
Wake Forest School of Medicine
Why?
Jeffrey S. Willey PhD
Wake Forest School of Medicine
Why?
Cristina M. Furdui PhD
Wake Forest School of Medicine
Why?
Ryan T. Hughes MD
Wake Forest School of Medicine
Why?
Linda J. Metheny-Barlow PhD
Wake Forest School of Medicine
Why?
Ravi N. Singh PhD
Wake Forest School of Medicine
Why?
Adrian W. Laxton MD
Wake Forest School of Medicine
Why?
John D. Bourland PhD
Wake Forest School of Medicine
Why?
Paul J. Black PhD
Wake Forest School of Medicine
Why?
Glenn J. Lesser MD
Wake Forest School of Medicine
Why?
Christopher Porada PhD
Wake Forest School of Medicine
Why?
Stephen R. Rapp PhD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 11
Next
Prev
Search Criteria
Radiation
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions